Polyradiculoneuropathy, Chronic Inflammatory Demyelinating: all 137 studies
Page 1 of 2. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.
- Multimodal Characterization of Movement Trajectories in Chronic Inflammatory Demyelinating PolyneuropathyRecruitingNCT07882797
- Clinical, Electrophysiological and Genetic Characteristics of Hereditary and Inflammatory Polyneuropathies in FranceNot yet recruitingNCT07851844
- Ultrasound-driven Stratification in CIDPNot yet recruitingNCT07719153
- An Exploratory Study of Obinutuzumab β in the Treatment of Chronic Inflammatory Demyelinating PolyradiculoneuropathyNot yet recruitingNCT07696377Phase 1/2
- A Study to Assess the Correct Dose, Safety and Efficacy of Empasiprubart in Adolescent Participants Aged 12 to Less Than 18 Years With Chronic Inflammatory Demyelinating PolyradiculoneuropathyNot yet recruitingNCT07638566Phase 2/3
- A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating PolyradiculoneuropathyRecruitingNCT07540221Phase 3
- Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.RecruitingNCT07526493Phase 1
- Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDPRecruitingNCT07461896
- CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune DiseasesRecruitingNCT07337785Early Phase 1
- Tongji NADs CohortNot yet recruitingNCT07333196
- Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual TreatmentRecruitingNCT07304154Phase 1
- Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart DevicesRecruitingNCT07273903
- Real-World Efgartigimod Effectiveness in CIDP: A Prospective StudyRecruitingNCT07264426
- Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)RecruitingNCT07154524
- Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating PolyneuropathyNot yet recruitingNCT07121985
- A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDPRecruitingNCT07091630Phase 3
- The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.Enrolling by invitationNCT07072676Not applicable
- Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)RecruitingNCT07032662Phase 2
- Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune DiseasesRecruitingNCT07022197Phase 1/2
- Vitaccess Real CIDP RegistryNot yet recruitingNCT07006597
- Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)RecruitingNCT06968975
- Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune DiseasesRecruitingNCT06939166Early Phase 1
- A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDPRecruitingNCT06920004Phase 3
- Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDPEnrolling by invitationNCT06859099Phase 3
- Ripertamab for the Treatment of Chronic Inflammatory Demyelinating PolyneuropathyNot yet recruitingNCT06858722Phase 3
- A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)RecruitingNCT06858579Phase 3
- A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)RecruitingNCT06798012Phase 2
- A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)RecruitingNCT06752356Phase 3
- A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)RecruitingNCT06747351Phase 3
- Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating PolyneuropathyRecruitingNCT06714838Phase 3
- A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune DisordersRecruitingNCT06680037Phase 1
- Our Study Aims to Determine if Nerve Alterations in Acute GBS and CIDP Detectable by Ultrasound Match Electrodiagnostic Findings and if This Method Aids Early Diagnosis, Predict Their Outcomes and Differentiate Between Axonal and Demyelinating Subtypes.RecruitingNCT06615622
- Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular DisordersEnrolling by invitationNCT06605612
- A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical CareRecruitingNCT06538064
- Biomarkers in Autoimmune Disease of Nervous SystemRecruitingNCT06502015
- Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.Not yet recruitingNCT06485232Early Phase 1
- Genetic Architecture of Chronic Inflammatory Demyelinating PolyradiculoneuropathyRecruitingNCT06325878Not applicable
- A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.RecruitingNCT06299748
- A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)RecruitingNCT06290141Phase 3
- Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.RecruitingNCT06183645
- RWE-based Treatment Patterns and Outcomes in CIDPNot yet recruitingNCT05940922
- IVIG vs SCIG in CIDPRecruitingNCT05584631Phase 1
- Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)RecruitingNCT05327114Phase 2/3
- Clinical and Electrophysiological Patterns of Chronic Dysimmune PolyneuropathyNot yet recruitingNCT05219383
- Biorepository and Registry for Plasma Exchange PatientsRecruitingNCT05004493
- Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)RecruitingNCT04881682Phase 2
- Pre-Approval Access for Efgartigimod PH20 SC in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)AvailableNCT04777734
- Hizentra® in Inflammatory Neuropathies - pHeNIx StudyRecruitingNCT04672733
- Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)RecruitingNCT04589299Phase 4
- Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous SystemRecruitingNCT04561557Early Phase 1
- Two Dose Levels of Privigen in Pediatric CIDPRecruitingNCT03684018Phase 4
- A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)CompletedNCT05084053Phase 3Results posted
- A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)CompletedNCT04281472Phase 2Results posted
- A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating PolyradiculoneuropathyCompletedNCT04051944Phase 2Results posted
- A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating PolyradiculoneuropathyCompletedNCT03861481Phase 2Results posted
- Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)TerminatedNCT03772717Not applicableResults posted
- A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347TerminatedNCT03275740Phase 1Results posted
- SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot StudyCompletedNCT02967679Phase 2Results posted
- Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDPCompletedNCT02955355Phase 3Results posted
- A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)CompletedNCT02549170Phase 3Results posted
- Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CompletedNCT02465359Not applicableResults posted
- Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302TerminatedNCT02317562Phase 3Results posted
- Efficacy and Safety Study of I10E in Treatment of Patients With CIDPCompletedNCT02293460Phase 3Results posted
- Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CompletedNCT02027701Phase 3Results posted
- Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.CompletedNCT01625182Phase 3Results posted
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)CompletedNCT01545076Phase 3Results posted
- Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT01184846Phase 3Results posted
- Lipoic Acid to Treat Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT00962429Phase 2Results posted
- Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT00278629Phase 2Results posted
- Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CompletedNCT00220740Phase 3Results posted
- Telitacicept for Refractory Chronic Inflammatory Demyelinating PolyneuropathyActive, not recruitingNCT07597733Not applicable
- Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular DiseaseActive, not recruitingNCT07478172Not applicable
- A First-in-Patient Clinical Trial of KINE-101 in Patients With Corticosteroid-Refractory CIDPCompletedNCT07343310Phase 1
- An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)TerminatedNCT07188844Phase 2
- Safety, Tolerability, and Efficacy of NVG-2089 in Participants With CIDPTerminatedNCT07027111Phase 2
- A Study to Assess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SCCompletedNCT06637072Phase 4
- Upper Limb Robot-Assisted Therapy in Patients With Guillain-Barré SyndromeActive, not recruitingNCT06620198Phase 4
- Rituximab in Chronic Inflammatory Demyelinating PolyradiculoneuropathyCompletedNCT06325943Phase 3
- A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not WorkActive, not recruitingNCT06290128Phase 3
- Polyneuropathy, Impairments and Physical Activity - The PolyImPAct StudyActive, not recruitingNCT06040567
- A Proof of Concept Study With Rituximab in Patients With CIDP Not Responding to Conventional Immune TherapyActive, not recruitingNCT05877040Phase 2
- Electronic Monitoring of Disease Activity in Patients With Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT05723848
- Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDPTerminatedNCT05614128
- To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDPTerminatedNCT05581199Phase 2
- Comparison of FEETME® Soles and GAITRITE® Walkway for the Evaluation of Gait Disorders in CIDP.TerminatedNCT05492604Not applicable
- A Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)CompletedNCT05363358
- Evaluation of the Diagnostic Contributions of Nerve Ultrasound in Chronic Inflammatory Demyelinating Polyneuropathy Associating Systemic Diseases (CIDP Echo-nerf)WithdrawnNCT05257733
- CIDP07 Rozanolixizumab Post Trial Access Program (the PTA)No longer availableNCT05014724
- NT-3 Levels and Function in Individuals With CMTTerminatedNCT05011006
- Role of High Frequency Ultrasound in Demyelinating PolyneuropathiesCompletedNCT04978623
- An Expanded Access IND for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)No longer availableNCT04825626
- Immunoglobulin G Therapy Dose OptimizationCompletedNCT04818177
- Effects of Single Plasma Exchange and Double Filtration Plasmapheresis (DFPP) on Peripheral Lymphocyte Phenotypes in Patients With Chronic Inflammatory Demyelinating PolyradiculoneuropathyCompletedNCT04742374Early Phase 1
- IA or PE - What is the Best Treatment Option of Steroid Refractory Neurological Autoimmune DiseasesCompletedNCT04687332Not applicable
- Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CompletedNCT04658472Phase 2
- InertiaLocoGraphy as a Biomarker of Immunoglobulin Therapy Efficacy in Chronic Inflammatory Demyelinating PolyradiculoneuropathyWithdrawnNCT04529291Not applicable
- Rituximab in Chronic Inflammatory Demyelinating PolyneuropathyWithdrawnNCT04480450Phase 2
- Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate DosingCompletedNCT04356781
- A Registered Cohort Study of Immune-Mediated NeuropathiesStatus unknownNCT04292834
- A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)Active, not recruitingNCT04280718Phase 2
← Polyradiculoneuropathy, Chronic Inflammatory Demyelinating overview